BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 28154563)

  • 1. Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for
    Stone BL; Brissette CA
    Front Immunol; 2017; 8():12. PubMed ID: 28154563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borrelia miyamotoi infection in nature and in humans.
    Krause PJ; Fish D; Narasimhan S; Barbour AG
    Clin Microbiol Infect; 2015 Jul; 21(7):631-9. PubMed ID: 25700888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of variable major protein antigenic variation in the relapsing fever spirochete, Borrelia miyamotoi, in response to polyclonal antibody selection pressure.
    Gilmore RD; Armstrong BA; Brandt KS; Van Gundy TJ; Hojgaard A; Lopez JE; Kneubehl AR
    PLoS One; 2023; 18(2):e0281942. PubMed ID: 36827340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. There Is a Method to the Madness: Strategies to Study Host Complement Evasion by Lyme Disease and Relapsing Fever Spirochetes.
    Marcinkiewicz AL; Kraiczy P; Lin YP
    Front Microbiol; 2017; 8():328. PubMed ID: 28303129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease- and relapsing fever-causing spirochetes.
    Roy S; Booth CE; Powell-Pierce AD; Schulz AM; Skare JT; Garcia BL
    J Biol Chem; 2023 Aug; 299(8):104972. PubMed ID: 37380082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Borrelia miyamotoi: a recently identified human pathogenic tick-borne relapsing fever spirochete].
    Szekeres S; Lakos A; Földvári G
    Orv Hetil; 2017 Jul; 158(29):1124-1130. PubMed ID: 28714333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H.
    Meri T; Cutler SJ; Blom AM; Meri S; Jokiranta TS
    Infect Immun; 2006 Jul; 74(7):4157-63. PubMed ID: 16790790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relapsing fever spirochete Borrelia miyamotoi resists complement-mediated killing by human serum.
    Teegler A; Herzberger P; Margos G; Fingerle V; Kraiczy P
    Ticks Tick Borne Dis; 2014 Oct; 5(6):898-901. PubMed ID: 25104575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable Major Proteins as Targets for Specific Antibodies against Borrelia miyamotoi.
    Wagemakers A; Koetsveld J; Narasimhan S; Wickel M; Deponte K; Bleijlevens B; Jahfari S; Sprong H; Karan LS; Sarksyan DS; van der Poll T; Bockenstedt LK; Bins AD; Platonov AE; Fikrig E; Hovius JW
    J Immunol; 2016 May; 196(10):4185-95. PubMed ID: 27076681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borrelia miyamotoi: A human tick-borne relapsing fever spirochete in Europe and its potential impact on public health.
    Siński E; Welc-Falęciak R; Zajkowska J
    Adv Med Sci; 2016 Sep; 61(2):255-260. PubMed ID: 27100337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eco-epidemiology of Borrelia miyamotoi and Lyme borreliosis spirochetes in a popular hunting and recreational forest area in Hungary.
    Szekeres S; Coipan EC; Rigó K; Majoros G; Jahfari S; Sprong H; Földvári G
    Parasit Vectors; 2015 Jun; 8():309. PubMed ID: 26048373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Immunocompetent Mouse Models for Borrelia miyamotoi Infection.
    Armstrong BA; Brandt KS; Goodrich I; Gilmore RD
    Microbiol Spectr; 2023 Jan; 11(2):e0430122. PubMed ID: 36715531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood transfusion transmission of the tick-borne relapsing fever spirochete Borrelia miyamotoi in mice.
    Krause PJ; Hendrickson JE; Steeves TK; Fish D
    Transfusion; 2015 Mar; 55(3):593-7. PubMed ID: 25251880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hide and Seek: How Lyme Disease Spirochetes Overcome Complement Attack.
    Kraiczy P
    Front Immunol; 2016; 7():385. PubMed ID: 27725820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Evasion Strategies of Relapsing Fever Spirochetes.
    Röttgerding F; Kraiczy P
    Front Immunol; 2020; 11():1560. PubMed ID: 32793216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borrelia miyamotoi - another emerging tick-borne pathogen.
    Kejíková R; Rudolf I
    Epidemiol Mikrobiol Imunol; 2021; 70(2):118-130. PubMed ID: 34412488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole genome sequencing of Borrelia miyamotoi isolate Izh-4: reference for a complex bacterial genome.
    Kuleshov KV; Margos G; Fingerle V; Koetsveld J; Goptar IA; Markelov ML; Kolyasnikova NM; Sarksyan DS; Kirdyashkina NP; Shipulin GA; Hovius JW; Platonov AE
    BMC Genomics; 2020 Jan; 21(1):16. PubMed ID: 31906865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borrelia miyamotoi: a widespread tick-borne relapsing fever spirochete.
    Wagemakers A; Staarink PJ; Sprong H; Hovius JW
    Trends Parasitol; 2015 Jun; 31(6):260-9. PubMed ID: 25892254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remarkable diversity of tick or mammalian-associated Borreliae in the metropolitan San Francisco Bay Area, California.
    Fedorova N; Kleinjan JE; James D; Hui LT; Peeters H; Lane RS
    Ticks Tick Borne Dis; 2014 Oct; 5(6):951-61. PubMed ID: 25129859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple and Diverse vsp and vlp Sequences in Borrelia miyamotoi, a Hard Tick-Borne Zoonotic Pathogen.
    Barbour AG
    PLoS One; 2016; 11(1):e0146283. PubMed ID: 26785134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.